KINDSTAR GLOBAL9960.HKValuation Analysis

As of Oct 16, 2026, KINDSTAR GLOBAL (9960.HK) trades at a negative P/E (-19.78x, due to a recent net loss), P/B of 0.32x, P/S of 0.87x, and a dividend yield of 10.50%.
Longitudinal percentile comparison: P/E historical percentile is still accumulating data over the trailing long-term window (vs. the short-term percentile still accumulating data); P/B sits at the 1st percentile over the trailing 10Y window (vs. 1st percentile over 3Y); P/S sits at the 1st percentile over the trailing 10Y window (vs. 1st percentile over 3Y).
Cross-sectional valuation: its P/B ranks at the 11th percentile within its industry and the 22nd percentile across the broader market.
Shareholder return highlight: Total Shareholder Yield is 10.77%, ranking at the 100th percentile over the trailing 20Y window.
The P/B percentile sits lower within its industry than across the market as a whole — relatively cheaper next to direct peers. Of the 10.77% total shareholder yield, 10.50% is paid out as dividends and roughly 0.27% is implied to come from buybacks — both channels are meaningfully in play. KINDSTAR GLOBAL operates in the Other Pharmaceuticals and Medical Services sector. Data refreshes weekly and is for reference only, not investment advice.